Medical Journal of the Islamic Republic of Iran · 2019 · 11 citations · 3 references
MedicineOncologyPathologyBone MetabolismBreast OncologyMetastasisBone MetastasisMalignant NeoplasmsMetastatic Bone DiseaseMetastatic Breast CancerMetastatic DisseminationTumor MarkersBone Metastasis LocalizationBone Tumor MetastasisBreast Cancer PrognosisCancer Antigen 15-3Cancer Metastasis BiomarkersMetastasis RiskMetastatic Bone Disease DetectionTumor Marker Assays
Background: Cancer antigen 15-3 (CA15-3) is a common tumor marker and the serum level of this tumor marker is evaluated during the treatment period (periodically) in breast cancer patients. Assuming that the elevated serum levels of this tumor marker can be a potential risk, this study was conducted to determine the association between CA15-3 and bone metastasis and CA15-3 and metastasis spreading rate in breast cancer patients.
3